In addition to data stating the effects of mutations on breast cancer, accumulating evidence indicates that MORC2 expression is upregulated in breast cancer and MORC2 overexpression is related to unfavorable pathological characteristics and poor prognosis. Here, MORC2 is linked to breast carcinoma.